Director, Chemical Development
Treeline · Watertown, MA · Yesterday
On-siteScienceFull-time
Responsibilities
- Lead and manage cross-functional teams engaged in external cGMP manufacturing of drug substance, DS intermediates, and starting materials.
- Collaborate with medicinal chemistry partners to support candidate selection and developability assessments. Advise and assist with sourcing scaffolds and intermediates as appropriate.
- Provide technical and functional project leadership on drug substance process development, manufacturing, and CDMO partner management.
- Oversee technical transfer activities between CDMOs as needed to ensure supply continuity.
- Collaborate with Analytical Development to ensure the development and validation of analytical test methods for drug substances.
- Ensure timely documentation review and approval to ensure supply continuity (Batch records, specifications, change controls, etc.).
- Provide technical input to deviation investigations to assess impact to product and manufacturing processes.
- Partner with Quality Assurance and CMC Regulatory to develop and implement appropriate processes and controls to ensure drug substance batches meet specifications and adhere to cGMP when required.
- Support investigations, root cause identification and CAPA implementation associated with manufacturing deviations and associated quality events.
- Work closely with Analytical Development/QC, Quality Assurance, Regulatory CMC, Supply Chain, and external manufacturing operations to ensure operational excellence with respect to timelines, budgets, and attainment of technical, regulatory and business goals/milestones.
- Author and review technical documents, process development reports, and drug substance sections for IND, IMPD, and global marketing applications.
- Stay current with applicable global regulations and industry standards.
- Represent Drug Substance and Chemical Development in meetings with FDA, EMA, and related regulatory authorities.
- May supervise one or more process chemists.
Qualifications
- Ph.D. in Organic Chemistry, or related discipline with a minimum of 12+ years of experience, or Master with a minimum of 15+ years of experience in the Chemical Development of small-molecule pharmaceuticals.
- Demonstrated successful leadership in a pharmaceutical CMC drug substance development role.
- Track record of success in leading and managing small-molecule drug substance programs in a 100% outsourced environment.
- Strong vendor/supplier management skills and excellent communication and cross-functional collaboration skills.
- Broad experience working with and managing external CDMO partners, including use of performance and quality metrics and MSA negotiation.
- Expertise in small molecule process development and oversight of GMP manufacturing, including tech transfer and process validation.
- Experience authoring and reviewing technical documents including, but not limited to, development reports, master batch records, analytical testing methods, and specifications.
- Deep understanding of global regulatory requirements for the manufacture, testing, and control of drug substances.
- Demonstrated success with authoring drug substance sections of INDs, IMPDs, and marketing applications, and practice responding to inquiries from regulatory agency reviews.
- Strong project leadership skills with the ability to manage complex timelines, multiple stakeholders, and evolving program priorities.
- Exceptional communication and collaboration skills with a proven ability to work cross-functionally in a fast-paced, science-driven environment.
- Understanding of basic budgeting processes.
- Understanding of industry trends, practices, techniques and standards, and associated impact on program strategy and execution.
- Ability to travel (20%) to CDMO domestic and international sites.
- Fluency with standard computer software packages (MS Word, Excel, PowerPoint, and Project) and JMP (or similar statistical tools).
- High level of personal integrity, commitment to excellence and to our patients.
- Experience in developing and commercializing drugs for oncology is preferred.